# Rosuvastatin and Renal Endothelial Function

> **NCT00160745** · PHASE2 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 46 (—)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT00160745
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 46 (—)
- **Last updated:** 2018-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160745, "Rosuvastatin and Renal Endothelial Function". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00160745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*